Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Simon Lovestone

PhD, MRCPsych


Professor of Translational Neuroscience

I am a clinician scientist working mostly on Alzheimer’s Disease but also on other neurodgeneration disorders such as Parkinson’s disease. Ultimately my group’s research is focussed on trying to find treatments, especially in the early preclinical or prodromal phase of disease. A successful therapy in this phase would delay or prevent symptoms; sometimes referred to as secondary prevention.

With this end in mind my team’s research includes understanding mechanisms and developing novel therapeutic targets, on finding biomarkers to facilitate clinical trials in the early phases of disease and the use of informatics to derive useful information from large datasets, both molecular and clinical.

The lab group’s work is described here http://www.psych.ox.ac.uk/research/dementia-research-group and the ARUK Oxford Drug Development Institute led by Lovestone and Bountra is here http://oxford-ddi.alzheimersresearchuk.org/

You can find me on Twitter here

 

 

True True

Recent Publications

5 View 407 more »